BRCA1 and neoplasm: Despite the advances made in vitro to decipher BRCA1 cellular functions, the importance of BRCA1 mutations in the clinical setting and the rapid escalation of the clinical use of PARP inhibitors, a deeper understanding of HGSC tumor molecular phenotypes is still necessary.